ClinicalTrials.govpublic full text
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
prostate cancer, castration resistant prostate cancer, pain, prostatic neoplasms, bone pain, crpc, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995420
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.